Shiv Rajan

Shiv Rajan

Auto-generated profile, based on publicly available information

Shiv Rajan

Surgical Oncology, King George’s Medical University, Uttar Pradesh, Lucknow, India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2021 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
DCD Chakrabarti
D Chakrabarti
SRS Rajan
S Rajan
NAN Akhtar
N Akhtar
SQS Qayoom
S Qayoom
SGS Gupta
S Gupta
RGR Gupta
R Gupta
The trial hypothesis was that, in a resource-constrained situation, short-course radiotherapy would improve treatment compliance compared with conventional chemoradiotherapy for locally advanced rectal cancer, without compromising oncological outcomes. In this open-label RCT, patients with cT3, cT4 or node-positive non-metastatic rectal cancer were allocated randomly to 5 × 5 Gy radiotherapy and two cycles of XELOX (arm A) or chemoradiotherapy with concurrent capecitabine (arm B), followed by total mesorectal excision in both arms. All patients received a further six cycles of adjuvant chemotherapy with the XELOX regimen. The primary endpoint was treatment compliance, defined as the ability to complete planned treatment, including neoadjuvant radiochemotherapy, surgery, and adjuvant chemotherapy to a dose of six cycles. Of 162 allocated patients, 140 were eligible for analysis: 69 in arm A and 71 in arm B. Compliance with planned treatment (primary endpoint) was greater in arm A (63 versus 41 per cent; P = 0.005). The incidence of acute toxicities of neoadjuvant therapy was similar (haematological: 28 versus 32 per cent, P = 0.533; gastrointestinal: 14 versus 21 per cent, P = 0.305; grade III–IV: 2 versus 4 per cent, P = 1.000). Delays in radiotherapy were less common in arm A (9 versus 45 per cent; P < 0.001), and overall times for completion of neoadjuvant treatment were shorter (P < 0.001). The rates of R0 resection (87 versus 90 per cent; P = 0.554), sphincter preservation (32 versus 35 per cent; P = 0.708), pathological complete response (12 versus 10 per cent; P = 0.740), and overall tumour downstaging (75 versus 75 per cent; P = 0.920) were similar. Downstaging of the primary tumour (ypT) was more common in arm A (P = 0.044). There was no difference in postoperative complications between trial arms (P = 0.838). Reduced treatment delays and a higher rate of compliance were observed with treatment for short-course radiotherapy with consolidation chemotherapy, with no difference in early oncological surgical outcomes. In time- and resource-constrained rectal cancer units in developing countries, short-course radiotherapy should be the standard of care.

16 February 2021 in Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
SRShiv Rajan
Shiv Rajan
NANaseem Akhtar
Naseem Akhtar
ATAbhilasha Tripathi
Abhilasha Tripathi
VKVijay Kumar
Vijay Kumar
ACArun Chaturvedi
Arun Chaturvedi
MSMohit Singh
Mohit Singh
Background: Coronavirus disease 2019 (COVID‐19) has impacted cancer care globally. The aim of this study is to analyze the impact of COVID‐19 on cancer healthcare from the perspective of patients with cancer.Methods: A cross‐sectional survey was conducted between June 19, 2020, to August 7, 2020, using a questionnaire designed by patients awaiting cancer surgery. We examined the impact of COVID‐19 on five domains (financial status, healthcare access, stress, anxiety, and depression) and their relationship with various patient‐related variables. Factors likely to determine the influence of COVID‐19 on patient care were analyzed.Results: A significant adverse impact was noted in all five domains (p = < 0.05), with the maximal impact felt in the domain of financial status followed by healthcare access. Patients with income levels of INR < 35 K (adjusted odds ratio [AOR] = 1.61, p < 0.05), and 35K‐ 100 K (AOR = 1.96, p < 0.05), married patients (AOR = 3.30, p < 0.05), and rural patients (AOR = 2.82, p < 0.05) experienced the most adverse COVID‐19‐related impact.Conclusion: Delivering quality cancer care in low to middle‐income countries is a challenge even in normal times. During this pandemic, deficiencies in this fragile healthcare delivery system were exacerbated. Identification of vulnerable groups of patients and strategic utilization of available resources becomes even more important during global catastrophes, such as the current COVID‐19 pandemic. Further work is required in these avenues to not only address the current pandemic but also any potential future crises.

10 February 2021 in Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
NANaseem Akhtar
Naseem Akhtar
SRShiv Rajan
Shiv Rajan
DCDeep Chakrabarti
Deep Chakrabarti
VKVijay Kumar
Vijay Kumar
SGSameer Gupta
Sameer Gupta
STShashwat Tiwari
Shashwat Tiwari
Background The novel coronavirus pandemic (COVID‐19) hinders the treatment of non‐COVID illnesses like cancer, which may be pronounced in lower‐middle‐income countries. Methods This retrospective cohort study audited the performance of a tertiary care surgical oncology department at an academic hospital in India during the first six months of the pandemic. Difficulties faced by patients, COVID‐19‐related incidents (preventable cases of hospital transmission), and modifications in practice were recorded. Results From April to September 2020, outpatient consultations, inpatient admissions, and chemotherapy unit functioning reduced by 62%, 58%, and 56%, respectively, compared to the same period the previous year. Major surgeries dropped by 31% with a decrease across all sites, but an increase in head and neck cancers (p = .012, absolute difference 8%, 95% confidence interval [CI]: 1.75% — 14.12%). Postoperative complications were similar (p = .593, 95% CI: −2.61% — 4.87%). Inability to keep a surgical appointment was primarily due to apprehension of infection (52%) or arranging finances (49%). Two COVID‐19‐related incidents resulted in infecting 27 persons. Fifteen instances of possible COVID‐19‐related mishaps were averted. Conclusions We observed a decrease in the operations of the department without any adverse impact in postoperative outcomes. While challenging, treating cancer adequately during COVID‐19 can be accomplished by adequate screening and testing, and religiously following the prevention guidelines.

1 August 2021 in Vaccine
Verified
Journal Article
Closed access
SRShiv Rajan
Shiv Rajan
NANaseem Akhtar
Naseem Akhtar
SSSonali Sharma
Sonali Sharma
DCDeep Chakrabarti
Deep Chakrabarti
VKVijay Kumar
Vijay Kumar

23 December 2019 in The Journal of Obstetrics and Gynecology of India
Verified
Journal Article
Closed access
PDF file
VKVijay Kumar
Vijay Kumar
SRShiv Rajan
Shiv Rajan
SGSameer Gupta
Sameer Gupta
NANaseem Akhtar
Naseem Akhtar
SSSonali Sharma
Sonali Sharma
ACArun Chaturvedi
Arun Chaturvedi

1 October 2020 in Journal of Oral Biology and Craniofacial Research
Verified
Journal Article
Closed access
SRShiv Rajan
Shiv Rajan
NANaseem Akhtar
Naseem Akhtar
VKVijay Kumar
Vijay Kumar
SGSameer Gupta
Sameer Gupta
SMSanjeev Misra
Sanjeev Misra
PSParijat Suryavanshi
Parijat Suryavanshi